Developing novel serosurveillance tools to monitor declining infection in the malaria elimination age

Speaker
  • Assistant Professor, LSHTM
    Biography
      Kevin joined the school in January 1999, working for Professor Eleanor Riley on the epidemiology of malaria. In June 2000 he moved from the Immunology Unit to the Pathogen Molecular Biology and Biochemistry (PMBB) Unit of the school to take up a postdoctoral position as a research fellow with Dr David Conway. The project is funded by the European Commission and is focused on the development of the N-terminal region of the merozoite surface protein (MSP) 1 as a vaccine candidate. Prior to joining the school Kevin had been studying for his PhD at Edinburgh University under the supervision of Professor Rick Maizels. His PhD project focused on the parasitic nematode Toxocara canis as a model system for the study of parasitic nematodes.

    Abstract

    Background and aim:
    Worldwide malaria cases have declined. However, despite recent advances, resistance to front line drugs and insecticides means the burden remains high (219 million cases in 2017). The World Health Organisation’s (WHO) Global Technical Strategy (GTS) milestone for 2020 was to eliminate  malaria from 10 countries. One of the three main aims towards achieving this was to “Transform malaria surveillance into a core intervention”. However, declining malaria also means increasing difficulty in detecting infections. Therefore, as countries approach elimination, additional measures are required to improve the sensitivity of surveillance. Antibodies are a sensitive marker of exposure that are acquired after each infection and lost over time. By focusing on markers of recent exposure, we have developed a serosurveillance panel and a prototype lateral flow device to help contribute to malaria elimination efforts.

    Methods:
    We have developed a number of novel malaria species-specific recombinant antigens and coupled these to MagPlex® Microspheres, or “beads”, to develop a novel multiplex serology assay. Using the MAGPIX® platform, we have screened serum samples or eluted dried blood spots to determine prevalence of exposure.

    Results:
    We have generated a rich dataset from malaria-endemic regions spanning a wide geographical range and contrasting endemicities, totaling >35,000 serum samples (and dried blood spots) since 2017. In addition, we have established the MAGPIX® platforms in most of these sites to aid sample access and knowledge transfer.

    Conclusion:
    Using the MAGPIX® platform, we have developed a unique panel of reagents to help detect exposure to three of the main causes of human malaria, Plasmodium falciparum, P.vivax and P.knowlesi.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    APR 01, 2021 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    DEC 15, 2020 10:00 AM PST
    C.E. CREDITS
    DEC 15, 2020 10:00 AM PST
    DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...

    Developing novel serosurveillance tools to monitor declining infection in the malaria elimination age


    No demographic data is available yet for this event.


    Show Resources
    Loading Comments...
    Show Resources